Corrigendum: Utility of S100A12 as an Early Biomarker in Patients With ST-Segment Elevation Myocardial Infarction

Frontiers in cardiovascular medicine(2022)

引用 1|浏览1
暂无评分
摘要
[This corrects the article DOI: 10.3389/fcvm.2021.747511.].
更多
查看译文
关键词
S100A12,ST-segment elevation myocardial infarction,cardiovascular disease(s),diagnosis,prognosis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要